These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 37794794)
1. Misdiagnosis of amyotrophic lateral sclerosis in clinical practice in Europe and the USA: a patient chart review and physician survey. Goyal NA; Bonar K; Savic N; Beau Lejdstrom R; Wright J; Mellor J; McDermott C Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):16-25. PubMed ID: 37794794 [TBL] [Abstract][Full Text] [Related]
2. Healthcare resource utilization at different stages of amyotrophic lateral sclerosis: Results from a real-world survey. Stenson K; O'Callaghan L; Mellor J; Wright J; Gibson G; Earl L; Barlow S; Fournier CN J Neurol Sci; 2023 Sep; 452():120764. PubMed ID: 37639764 [TBL] [Abstract][Full Text] [Related]
3. The amyotrophic lateral sclerosis (ALS) patient perspective on misdiagnosis and its repercussions. Belsh JM; Schiffman PL J Neurol Sci; 1996 Aug; 139 Suppl():110-6. PubMed ID: 8899669 [TBL] [Abstract][Full Text] [Related]
4. Time from amyotrophic lateral sclerosis symptom onset to key disease milestones: analysis of data from a multinational cross-sectional survey. Gebrehiwet P; Brekke J; Rudnicki SA; Mellor J; Wright J; Earl L; Ball N; Iqbal H; Thomas O; Castellano G Amyotroph Lateral Scler Frontotemporal Degener; 2024 May; 25(3-4):345-357. PubMed ID: 38156828 [TBL] [Abstract][Full Text] [Related]
5. The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: A population- based study of consultations, interventions and costs. Galvin M; Ryan P; Maguire S; Heverin M; Madden C; Vajda A; Normand C; Hardiman O PLoS One; 2017; 12(6):e0179796. PubMed ID: 28640860 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the diagnostic pathway and delay in patients with amyotrophic lateral sclerosis in the Valencian Community. Vázquez-Costa JF; Martínez-Molina M; Fernández-Polo M; Fornés-Ferrer V; Frasquet-Carrera M; Sevilla-Mantecón T Neurologia (Engl Ed); 2021 Sep; 36(7):504-513. PubMed ID: 34537164 [TBL] [Abstract][Full Text] [Related]
7. An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United States, and Europe. Takei K; Tsuda K; Takahashi F; Hirai M; Palumbo J Amyotroph Lateral Scler Frontotemporal Degener; 2017 Oct; 18(sup1):88-97. PubMed ID: 28872912 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic delay in amyotrophic lateral sclerosis. Gwathmey KG; Corcia P; McDermott CJ; Genge A; Sennfält S; de Carvalho M; Ingre C Eur J Neurol; 2023 Sep; 30(9):2595-2601. PubMed ID: 37209406 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres. Marin B; Beghi E; Vial C; Bernard E; Lautrette G; Clavelou P; Guy N; Lemasson G; Debruxelles S; Cintas P; Antoine JC; Camdessanche JP; Logroscino G; Preux PM; Couratier P; Eur J Neurol; 2016 Apr; 23(4):787-95. PubMed ID: 26833536 [TBL] [Abstract][Full Text] [Related]
11. Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe. Armuzzi A; DiBonaventura MD; Tarallo M; Lucas J; Bluff D; Hoskin B; Bargo D; Cappelleri JC; Quirk D; Salese L PLoS One; 2020; 15(1):e0227914. PubMed ID: 31945774 [TBL] [Abstract][Full Text] [Related]
13. Limb-onset amyotrophic lateral sclerosis patients visiting orthopedist show a longer time-to-diagnosis since symptom onset. Kano O; Iwamoto K; Ito H; Kawase Y; Cridebring D; Ikeda K; Iwasaki Y BMC Neurol; 2013 Feb; 13():19. PubMed ID: 23394455 [TBL] [Abstract][Full Text] [Related]
14. Health services utilization prior to amyotrophic lateral sclerosis diagnosis: A province-wide study of individuals treated with riluzole in Ontario, Canada. Campitelli MA; Abrahao A; Maclagan LC; Fu L; Maxwell CJ; Swartz RH; Zinman L; Bronskill SE Muscle Nerve; 2021 Dec; 64(6):691-700. PubMed ID: 34437716 [TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010-2015. Raymond J; Oskarsson B; Mehta P; Horton K Amyotroph Lateral Scler Frontotemporal Degener; 2019 Aug; 20(5-6):413-420. PubMed ID: 31131638 [No Abstract] [Full Text] [Related]
16. Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database. Williams JR; Fitzhenry D; Grant L; Martyn D; Kerr DA BMC Neurol; 2013 Nov; 13():160. PubMed ID: 24499173 [TBL] [Abstract][Full Text] [Related]
17. Amyotrophic lateral sclerosis care in Italy: a nationwide study in neurological centers. Chiò A; Silani V; J Neurol Sci; 2001 Oct; 191(1-2):145-50. PubMed ID: 11677006 [TBL] [Abstract][Full Text] [Related]
18. Current treatment pathways in ALS: a European perspective. Dengler R Neurology; 1999; 53(8 Suppl 5):S4-10; discussion S20-1. PubMed ID: 10560630 [TBL] [Abstract][Full Text] [Related]
19. Clinical Course of Amyotrophic Lateral Sclerosis according to Initial Symptoms: An Analysis of 500 Cases. Lee JW; Kang SW; Choi WA Yonsei Med J; 2021 Apr; 62(4):338-343. PubMed ID: 33779087 [TBL] [Abstract][Full Text] [Related]
20. Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world survey. Mahic M; Bozorg A; DeCourcy J; Golden K; Gibson G; Taylor C; Scowcroft A Orphanet J Rare Dis; 2023 Jun; 18(1):169. PubMed ID: 37386469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]